Cargando…

SARS-CoV-2 reinfection or persistence among immunodeficient patients

Detalles Bibliográficos
Autor principal:	Özdemir, Öner
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Academy of Allergy, Asthma & Immunology 2023
Materias:	Correspondence and Replies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989330/ https://www.ncbi.nlm.nih.gov/pubmed/36894284 http://dx.doi.org/10.1016/j.jaip.2022.10.057

Ejemplares similares

Reply to “SARS-CoV-2 reinfection or persistence among immunodeficient patients”
por: Marcus-Mandelblit, Nufar, et al.
Publicado: (2023)

The impact of inhaled corticosteroid on SARS-CoV2 infection
por: Lai, Chih-Cheng
Publicado: (2021)

A case of SARS-CoV-2 reinfection in Ecuador
por: Prado-Vivar, Belén, et al.
Publicado: (2021)

Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections
por: Abu-Raddad, Laith J., et al.
Publicado: (2021)

Viable virus shedding during SARS-CoV-2 reinfection
por: Letizia, Andrew G, et al.
Publicado: (2021)

Reinfection with SARS-CoV-2: A case report from Libya
por: Teka, Ibrahim A., et al.
Publicado: (2021)

Optimising the initial investigation of suspected cases of SARS-CoV-2 reinfection
por: Pallett, Scott JC., et al.
Publicado: (2021)

Immune Imprinting and Protection against Repeat Reinfection with SARS-CoV-2
por: Chemaitelly, Hiam, et al.
Publicado: (2022)

Structured serological testing is an essential component to investigating SARS-CoV-2 reinfection
por: Pallett, Scott J C, et al.
Publicado: (2021)

Efficacy of Natural Immunity against SARS-CoV-2 Reinfection with the Beta Variant
por: Chemaitelly, Hiam, et al.
Publicado: (2021)

SARS-CoV-2 reinfection in two patients who have recovered from COVID-19
por: Zhang, Kang, et al.
Publicado: (2020)

Persistent Viral Shedding after SARS-CoV-2 Infection in an Infant with Severe Combined Immunodeficiency
por: Hariharan, Sankar Vaikom, et al.
Publicado: (2021)

Author’s reply to comment on: A higher frequency of physical activity is associated with reduced rates of SARS-CoV-2 infection
por: Green, Ilan, et al.
Publicado: (2023)

Reply to Schulte-Pelkum, J. Comment on “Favresse et al. Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for Up to 10 Months after Infection. Microorganisms 2021, 9, 556”
por: Favresse, Julien, et al.
Publicado: (2021)

Persistence and viability of SARS-CoV-2 in primary infection and reinfections
por: Ruiz-Galiana, Julián, et al.
Publicado: (2021)

Reply to Ialongo et al. Vitamin D, SARS-CoV-2 and Causal Associations in Transversal Studies: The Time-Series Analysis to Reveal Potential Confounders. Comment on “Gaudio et al. Vitamin D Levels Are Reduced at the Time of Hospital Admission in Sicilian SARS-CoV-2-Positive Patients. Int. J. Environ. Res. Public Health 2021, 18, 3491”
por: Gaudio, Agostino, et al.
Publicado: (2021)

SARS-CoV-2 reinfection()
por: Romera, I., et al.
Publicado: (2021)

Reply to Taylor et al. Comment on “Manna et al. SARS-CoV-2 Inactivation in Aerosol by Means of Radiated Microwaves. Viruses 2023, 15, 1443”
por: Manna, Antonio, et al.
Publicado: (2023)

Reply to Letter to the Editor: “How Does SARS-CoV-2 Fragment the QRS?”
por: Halil Özdemir, İbrahim, et al.
Publicado: (2022)

Continued False‐Positive Detection of SARS‐CoV‐2 by Electron Microscopy
por: Dittmayer, Carsten, et al.
Publicado: (2022)

Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
por: Choi, Bina, et al.
Publicado: (2020)

Reply to: Before attributing encephalomyelitis to SARS‐CoV‐2 vaccinations exclude differentials
por: Kania, Karolina, et al.
Publicado: (2021)

Reply to Kulić, Ž. Comment on “Subhadra et al. Significant Broad-Spectrum Antiviral Activity of Bi121 against Different Variants of SARS-CoV-2. Viruses 2023, 15, 1299”
por: Subhadra, Bobban, et al.
Publicado: (2023)

Reinfection and reactivation of SARS-CoV-2
por: Dowran, Razieh, et al.
Publicado: (2022)

Reply to McDonald, “Protections against the Risk of Airborne SARS-CoV-2 Infection”
por: Dietz, Leslie, et al.
Publicado: (2020)

COVID-19 reinfections in The Gambia by phylogenetically distinct SARS-CoV-2 variants—first two confirmed events in west Africa
por: Sanyang, Bakary, et al.
Publicado: (2021)

Asymptomatic SARS-CoV-2 infected patients with persistent negative CT findings
por: Ling, Zhoukun, et al.
Publicado: (2020)

Clinical and laboratory outcomes of the solid cancer patients reinfected with SARS-CoV-2
por: Ünsal, Oktay, et al.
Publicado: (2021)

Reply to Zandi, M.; Soltani, S. Comment on “Alfassam et al. Development of a Colorimetric Tool for SARS-CoV-2 and Other Respiratory Viruses Detection Using Sialic Acid Fabricated Gold Nanoparticles. Pharmaceutics 2021, 13, 502”
por: Alfassam, Haya A., et al.
Publicado: (2022)

Protective effect of plasma neutralization from prior SARS-CoV-2 Omicron infection against BA.5 subvariant symptomatic reinfection
por: Chen, Xiaosu, et al.
Publicado: (2023)

Reinfection With SARS-CoV-2: Implications for Vaccines
por: Cohen, Jeffrey I, et al.
Publicado: (2020)

Serological Markers of SARS-CoV-2 Reinfection
por: Siddiqui, Sameed M., et al.
Publicado: (2022)

Reinfection with SARS-CoV-2: An inconvenient truth?
por: Sonié, Pedro, et al.
Publicado: (2022)

Epidemiological assessment of SARS-CoV-2 reinfection
por: Almadhi, Marwa, et al.
Publicado: (2022)

Reinfection, recontamination and revaccination for SARS-CoV-2
por: Kullmann, Tamás, et al.
Publicado: (2022)

Severe sinus bradycardia associated with remdesivir in a child with severe SARS-COV-2 infection—reply
por: Mendez-Echevarria, Ana, et al.
Publicado: (2021)

Phylogenomic Evidence of Reinfection and Persistence of SARS-CoV-2: First Report from Colombia
por: Ramírez, Juan David, et al.
Publicado: (2021)

Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection
por: Reuken, Philipp A., et al.
Publicado: (2021)

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Standl, Fabian, et al.
Publicado: (2021)

Reply to Fabbris et al. A Viable Alternative. Comment on “Kohmer et al. Self-Collected Samples to Detect SARS-CoV-2: Direct Comparison of Saliva, Tongue Swab, Nasal Swab, Chewed Cotton Pads and Gargle Lavage. J. Clin. Med. 2021, 10, 5751”
por: Hoehl, Sebastian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f3vi782r16suucedtdvcos2lid